A global drug development consultancy helping to translate ideas into medicinal products and treatments for patient benefit.
At Boyds, we bring together a wide range of expertise and skills central to the development of pharmaceutical and biotechnology medicinal products and medical devices. We specialize in ATMPs, cell and gene therapies, and orphan drugs, focusing on innovative medicinal products and treatments.
Boyds partners with pharma companies, biotechs, spin-outs, and academic groups to support cutting-edge drug development. Our team provides scientific, clinical, and regulatory expertise to guide clients from concept to clinic, accelerating the pathway to patients.
Your trusted partner in global drug development.
Our track record reflects two decades of scientific expertise, regulatory insight, and trusted partnerships that help bring new medicines to patients.
Years supporting global biopharma development
Clients supported
Cell & gene therapies approved with Boyds’ support
Client Satisfaction Rate
Our services
Boyds provides the perfect synergy between theoretical understanding and real-world practical applications.
Clinical & Medical Affairs
Regulatory Submission Management
Regulatory and Medical Writing
Latest news & insights
Recent Resources
Delivering a high-priority FDA submission: Regulatory Operations excellence under pressure
Read more >
Accelerate your path from discovery to approval.
Boyds helps life science innovators bring new medicines and therapies to patients.
